State of the art in myeloid sarcoma

International Journal of Laboratory Hematology

Volumn 33, Issue 6, 2011, Pages 555-565

  Klco, J M ^a   Welch, J S ^a   Nguyen, T T ^a   Hurley, M Y ^b   Kreisel, F H ^a   Hassan, A ^a   Lind, A C ^a   Frater, J L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Granulocytic sarcoma; Monoblastic sarcoma; Myeloid sarcoma

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; LEUKOSIALIN; LYSOZYME; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; CANCER MORPHOLOGY; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DONOR LYMPHOCYTE INFUSION; FLOW CYTOMETRY; GRANULOCYTIC SARCOMA; HISTIOCYTIC SARCOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; IMMUNOTHERAPY; LARGE CELL LYMPHOMA; MEDICAL LITERATURE; MELANOMA; NONHODGKIN LYMPHOMA; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; SENSITIVITY AND SPECIFICITY;

ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHILD; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-KIT; SARCOMA, MYELOID; TUMOR MARKERS, BIOLOGICAL;

EID: 80054690162     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2011.01361.x     Document Type: Review

References (63)

1. Alexiev B.A., Wang W., Ning Y., Chumsri S., Gojo I., Rodgers W.H., Stass S.A. & Zhao X.F. (2007) Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study. Diagnostic Pathology 2, 42.
2. Ansari-Lari M.A., Yang C.F., Tinawi-Aljundi R., Cooper L., Long P., Allan R.H., Borowitz M.J., Berg K.D. & Murphy K.M. (2004) FLT3 mutations in myeloid sarcoma. British Journal Haematology 126, 785-791.
3. Assaf C., Gellrich S., Whittaker S., Robson A., Cerroni L., Massone C., Kerl H., Rose C., Chott A., Chimenti S., Hallermann C., Petrella T., Wechsler J., Bagot M., Hummel M., Bullani-Kerl K., Bekkenk M.W., Kempf W., Meijer C.J., Willemze R. & Sterry W. (2007) CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer. Journal of Clinical Pathology 60, 981-989.
4. Baer M.R., Stewart C.C., Dodge R.K., Leget G., Sule N., Mrozek K., Schiffer C.A., Powell B.L., Kolitz J.E., Moore J.O., Stone R.M., Davey F.R., Carroll A.J., Larson R.A. & Bloomfield C.D. (2001) High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 97, 3574-3580.
5. Benet C., Gomez A., Aguilar C., Delattre C., Vergier B., Beylot-Barry M., Fraitag S., Carlotti A., Dechelotte P., Hospital V., d'Incan M., Costes V., Dereure O., Ortonne N., Bagot M., Laroche L., Blom A., Dalac S. & Petrella T. (2011) Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. American Journal of Clinical Pathology 135, 278-290.
6. Betz B.L. & Hess J.L. (2010) Acute myeloid leukemia diagnosis in the 21st century. Archives of Pathology and Laboratory Medicine 134, 1427-1433.
7. Bonig H., Gobel U. & Nurnberger W. (2002) Bilateral exopthalmus due to retro-orbital chloromas in a boy with t(8;21)- positive acute myeloblastic acute leukemia. Pediatric Hematology and Oncology 19, 597-600.
8. Bovio I.M. & Allan R.W. (2008) The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK+ anaplastic large cell lymphomas. American Journal of Clinical Pathology 130, 628-634.
9. Byrd J.C., Edenfield W.J., Shields D.J. & Dawson N.A. (1995) Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. Journal of Clinical Oncology 13, 1800-1816.
10. Campidelli C., Agostinelli C., Stitson R. & Pileri S.A. (2009) Myeloid sarcoma: extramedullary manifestation of myeloid disorders. American Journal of Clinical Pathology 132, 426-437.
11. Chang C.C., Eshoa C., Kampalath B., Shidham V.B. & Perkins S. (2000) Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow. American Journal of Clinical Pathology 114, 807-811.
12. Chang H., Brandwein J., Yi Q.L., Chun K., Patterson B. & Brien B. (2004) Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leukemia Research 28, 1007-1011.
13. Clark W.B., Strickland S.A., Barrett A.J. & Savani B.N. (2010) Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome. Haematologica 95, 860-863.
14. Deeb G., Baer M.R., Gaile D.P., Sait S.N., Barcos M., Wetzler M., Conroy J.M., Nowak N.J., Cowell J.K. & Cheney R.T. (2005) Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosomes Cancer 44, 373-383.
15. Del Poeta G., Stasi R., Venditti A., Cox C., Aronica G., Masi M., Bruno A., Simone M.D., Buccisano F. & Papa G. (1995) CD7 expression in acute myeloid leukemia. Leukaemia & Lymphoma 17, 111-119.
16. Dong H.Y., Wilkes S. & Yang H. (2011) CD71 is selectively and ubiquitously expressed at high levels in erythroid precursors of all maturation stages: a comparative immunochemical study with glycophorin A and hemoglobin A. American Journal of Surgical Pathology 35, 723-732.
17. Dunphy C.H., O'Malley D.P., Perkins S.L. & Chang C.C. (2007) Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias. Applied Immunohistochemistry & Molecular Morphology 15, 154-159.
18. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A., Bigerna B., Pacini R., Pucciarini A., Liso A., Vignetti M., Fazi P., Meani N., Pettirossi V., Saglio G., Mandelli F., Lo-Coco F., Pelicci P.G. & Martelli M.F. (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New England Journal of Medicine 352, 254-266.
19. Falini B., Lenze D., Hasserjian R., Coupland S., Jaehne D., Soupir C., Liso A., Martelli M.P., Bolli N., Bacci F., Pettirossi V., Santucci A., Martelli M.F., Pileri S. & Stein H. (2007) Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia 21, 1566-1570.
20. Feuillard J., Jacob M.C., Valensi F., Maynadie M., Gressin R., Chaperot L., Arnoulet C., Brignole-Baudouin F., Drenou B., Duchayne E., Falkenrodt A., Garand R., Homolle E., Husson B., Kuhlein E., Le Calvez G., Sainty D., Sotto M.F., Trimoreau F. & Bene M.C. (2002) Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 99, 1556-1563.
21. Foa R., Casorati G., Giubellino M.C., Basso G., Schiro R., Pizzolo G., Lauria F., Lefranc M.P., Rabbitts T.H. & Migone N. (1987) Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia. The Journal of Experimental Medicine 165, 879-890.
22. Hancock J.C., Prchal J.T., Bennett J.M. & Listinsky C.M. (1997) Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome. Archives of Pathology and Laboratory Medicine 121, 520-523.
23. Haresh K.P., Joshi N., Gupta C., Prabhakar R., Sharma D.N., Julka P.K. & Rath G.K. (2008) Granulocytic sarcoma masquerading as Ewing's sarcoma: a diagnostic dilemma. Journal of Cancer Research and Therapeutics 4, 137-139.
24. Hirose Y., Masaki Y., Shimoyama K., Sugai S. & Nojima T. (2001) Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years. European Journal of Haematology 67, 194-198.
25. Hoyer J.D., Grogg K.L., Hanson C.A., Gamez J.D. & Dogan A. (2008) CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage. American Journal of Clinical Pathology 129, 316-323.
26. Jackson C.C., Medeiros L.J. & Miranda R.N. (2010) 8p11 myeloproliferative syndrome: a review. Human Pathology 41, 461-476.
27. Jaffe E.S., Harris N.L., Stein H. & Vardiman J.W. eds. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
28. Kaiserling E., Horny H.P., Geerts M.L. & Schmid U. (1994) Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Modern Pathology 7, 771-779.
29. Kang L.C. & Dunphy C.H. (2006) Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes. Archives of Pathology and Laboratory Medicine 130, 153-157.
30. King A. (1853) A case of chloroma. Monthly Journal of the Medical Society 17, 17.
31. Klco J.M., Kulkarni S., Kreisel F.H., Nguyen T.D., Hassan A. & Frater J.L. (2011) Immunohistochemical analysis of monocytic leukemias: usefulness of CD14 and Kruppel-like factor 4, a novel monocyte marker. American Journal of Clinical Pathology 135, 720-730.
32. Koc Y., Miller K.B., Schenkein D.P., Daoust P., Sprague K. & Berkman E. (1999) Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 85, 608-615.
33. Kuan J.W., Pathmanathan R., Chang K.M. & Tan S.M. (2009) Aleukemic bcr-abl positive granulocytic sarcoma. Leukemia Research 33, 1574-1577.
34. Lan T.Y., Lin D.T., Tien H.F., Yang R.S., Chen C.Y. & Wu K. (2009) Prognostic factors of treatment outcomes in patients with granulocytic sarcoma. Acta Haematologica 122, 238-246.
35. Lau S.K., Chu P.G. & Weiss L.M. (2004) CD163: a specific marker of macrophages in paraffin-embedded tissue samples. American Journal of Clinical Pathology 122, 794-801.
36. Lewis R.E., Cruse J.M., Sanders C.M., Webb R.N. & Suggs J.L. (2007) Aberrant expression of T-cell markers in acute myeloid leukemia. Experimental and Molecular Pathology 83, 462-463.
37. Macedo A., San Miguel J.F., Vidriales M.B., Lopez-Berges M.C., Garcia-Marcos M.A., Gonzalez M., Landolfi C. & Orfao A. (1996) Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease. Journal of Clinical Pathology 49, 15-18.
38. Marsee D.K., Pinkus G.S. & Yu H. (2010) CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens. American Journal of Clinical Pathology 134, 429-435.
39. Menasce L.P., Banerjee S.S., Beckett E. & Harris M. (1999) Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases. Histopathology 34, 391-398.
40. Mrozek K., Radmacher M.D., Bloomfield C.D. & Marcucci G. (2009) Molecular signatures in acute myeloid leukemia. Current Opinion in Hematology 16, 64-69.
41. Neiman R.S., Barcos M., Berard C., Bonner H., Mann R., Rydell R.E. & Bennett J.M. (1981) Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases. Cancer 48, 1426-1437.
42. Newman P.J. (1997) The biology of PECAM-1. Journal of Clinical Investigation 99, 3-8.
43. Nguyen T.T., Schwartz E.J., West R.B., Warnke R.A., Arber D.A. & Natkunam Y. (2005) Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. American Journal of Surgical Pathology 29, 617-624.
44. Olsen R.J., Chang C.C., Herrick J.L., Zu Y. & Ehsan A. (2008) Acute leukemia immunohistochemistry: a systematic diagnostic approach. Archives of Pathology and Laboratory Medicine 132, 462-475.
45. O'Malley D.P. (2007) Benign extramedullary myeloid proliferations. Modern Pathology 20, 405-415.
46. Orazi A., O'Malley D.P., Jiang J., Vance G.H., Thomas J., Czader M., Fang W., An C. & Banks P.M. (2005) Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia. Modern Pathology 18, 603-614.
47. Petrella T., Meijer C.J., Dalac S., Willemze R., Maynadie M., Machet L., Casasnovas O., Vergier B. & Teitell M.A. (2004) TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. American Journal of Clinical Pathology 122, 307-313.
48. Petrella T., Bagot M., Willemze R., Beylot-Barry M., Vergier B., Delaunay M., Meijer C.J., Courville P., Joly P., Grange F., De Muret A., Machet L., Dompmartin A., Bosq J., Durlach A., Bernard P., Dalac S., Dechelotte P., D'Incan M., Wechsler J. & Teitell M.A. (2005) Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. American Journal of Clinical Pathology 123, 662-675.
49. Pileri S.A., Grogan T.M., Harris N.L., Banks P., Campo E., Chan J.K., Favera R.D., Delsol G., De Wolf-Peeters C., Falini B., Gascoyne R.D., Gaulard P., Gatter K.C., Isaacson P.G., Jaffe E.S., Kluin P., Knowles D.M., Mason D.Y., Mori S., Muller-Hermelink H.K., Piris M.A., Ralfkiaer E., Stein H., Su I.J., Warnke R.A. & Weiss L.M. (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology 41, 1-29.
50. Pileri S.A., Ascani S., Cox M.C., Campidelli C., Bacci F., Piccioli M., Piccaluga P.P., Agostinelli C., Asioli S., Novero D., Bisceglia M., Ponzoni M., Gentile A., Rinaldi P., Franco V., Vincelli D., Pileri Jr A., Gasbarra R., Falini B., Zinzani P.L. & Baccarani M. (2007) Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21, 340-350.
51. Quintanilla-Martinez L., Zukerberg L.R., Ferry J.A. & Harris N.L. (1995) Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification. American Journal of Clinical Pathology 104, 431-443.
52. Ratnam K.V., Su W.P., Ziesmer S.C. & Li C.Y. (1992) Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers. Journal of Cutaneous Pathology 19, 193-200.
53. Sano F., Tasaka T., Nishimura H., Akiyama T., Kubo Y., Matsuhashi Y., Wada H, Sugihara T., Yamakawa M. & Sadahira Y. (2008) A peculiar case of acute myeloid leukemia mimicking plasmacytoid dendritic precursor cell leukemia. Journal of Clinical and Experimental Hematopathology 48, 65-69.
54. Sen F., Zhang X.X., Prieto V.G., Shea C.R. & Qumsiyeh M.B. (2000) Increased incidence of trisomy 8 in acute myeloid leukemia with skin infiltration (leukemia cutis). Diagnostic Molecular Pathology 9, 190-194.
55. Song M.J., Kim H.J., Ko Y.H. & Kim S.H. (2009) Discrepant immunophenotypic characteristics between the lymph node and bone marrow in two mixed-phenotype acute leukemia patients. Korean Journal of Laboratory Medicine 29, 396-401.
56. Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J. & Vardiman J.W. eds. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue. IARC Press, Lyon, France.
57. Traweek S.T., Arber D.A., Rappaport H. & Brynes R.K. (1993) Extramedullary myeloid cell tumors. An immunohistochemical and morphologic study of 28 cases. American Journal of Surgical Pathology 17, 1011-1019.
58. Tsimberidou A.M., Kantarjian H.M., Wen S., Keating M.J., O'Brien S., Brandt M., Pierce S., Freireich E.J., Medeiros L.J. & Estey E. (2008) Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer 113, 1370-1378.
59. Vedy D., Muehlematter D., Rausch T., Stalder M., Jotterand M. & Spertini O. (2010) Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib. Journal of Clinical Oncology 28, e33-e35.
60. Vega F., Medeiros L.J., Davuluri R., Cromwell C.C., Alkan S. & Abruzzo L.V. (2008) t(8;13)-positive bilineal lymphomas: report of 6 cases. American Journal of Surgical Pathology 32, 14-20.
61. Vega-Ruiz A., Faderl S., Estrov Z., Pierce S., Cortes J., Kantarjian H. & Ravandi F. (2009) Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience. International Journal of Hematology 89, 489-496.
62. Yang D.H., Lee J.J., Mun Y.C., Shin H.J., Kim Y.K., Cho S.H., Chung I.J., Seong C.M. & Kim H.J. (2007) Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation. American Journal of Hematology 82, 1-5.
63. Zuo Z., Polski J.M., Kasyan A. & Medeiros L.J. (2010) Acute erythroid leukemia. Archives of Pathology and Laboratory Medicine 134, 1261-1270.